You are here

Treatments

President Biden tests positive for Covid-19, mild symptoms

Thu, 2024-07-18 14:42 — mike kraft

President Joe Biden tests positive for Covid-19 at pivotal moment in reelection campaign | CNN Politics President Joe Biden tested positive for Covid-19 on Wednesday, disrupting a key campaign event meant to shore up Latino voters at a critical juncture in the run-up to the election. Priscilla Alvarez, Donald Judd, Piper HudspethBlackburn CNN

...

Biden, 81, was experiencing mild symptoms and has received his first dose of the antiviral drug Paxlovid, according to his doctor.

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about President Biden tests positive for Covid-19, mild symptoms
Log in or register to post comments

Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs --study

Wed, 2024-07-17 14:59 — mike kraft

Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs Hospitalized COVID-19 patients treated with the antiviral drug nirmatrelvir–ritonavir (Paxlovid) are at lower risk for death, intensive care unit (ICU) admission, and need for ventilation than those given a combination of Paxlovid and the antiviral drug remdesivir (Veklury) or Veklury alone, a University of Hong Kong target trial emulation study suggests. CIDRAP

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Paxlovid led to better outcomes in hospitalized COVID cohort than Veklury or both drugs --study
Log in or register to post comments

Which factors have an impact on the risk of post-COVID condition--German study

Fri, 2024-07-05 15:25 — mike kraft

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about Which factors have an impact on the risk of post-COVID condition--German study
Log in or register to post comments

Remdesivir lowered risk of death among hospitalized COVID patients by 54% --study

Thu, 2024-06-27 00:01 — mike kraft

Remdesivir tied to 54% lower risk of death among hospitalized COVID patients A comparison study based on two large, open-label studies links the antiviral drug remdesivir (Veklury) to a 54% lower risk of all-cause death and shorter hospital stays compared with standard of care (SOC) alone in hospitalized COVID-19 patients requiring supplemental oxygen in 2020. CIDRAP

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Remdesivir lowered risk of death among hospitalized COVID patients by 54% --study
Log in or register to post comments

Extreme heat wave in parts of the U.S: suggestions on how to protect yourself if you can’t stay indoors

Tue, 2024-06-18 15:34 — mike kraft

How to protect yourself during a heat wave if you can't stay indoors FARMINGTON HILLS, Mich. (AP) — It’s hot and getting hotter for workers and everyone else outdoors as the first significant heat wave of the year makes its way eastward across the United States. More than 70 million people were under extreme heat alerts Monday. What's more, the heat will move in and sit. Excessive humidity will make it feel even more oppressive. “The duration of this heat wave is notable and potentially the longest experienced PBS NewsHour

...

Country / Region Tags:

General Topic Tags:

Extreme Weather

Problem, Solution, SitRep, or ?:

Situation Report

New US poll shows fair amount of common ground on preventive COVID-19 steps

Mon, 2024-06-17 23:42 — mike kraft

US poll shows fair amount of common ground on preventive COVID-19 steps A new poll from researchers at the Harvard T.H. Chan School of Public Health and the de Beaumont Foundation shows that, despite news coverage that painted Americans as deeply divided on COVID-19 mitigation strategies, including mask wearing, there was significant common ground on these strategies in hindsight. CIDRAP

Country / Region Tags:

General Topic Tags:

Disease Prevention

Public Attitudes

Social behavior

Problem, Solution, SitRep, or ?:

Situation Report

Read more about New US poll shows fair amount of common ground on preventive COVID-19 steps
Log in or register to post comments

National Academy of Sciences urges federal government and medical profession to develop a common definition of long Covid

Thu, 2024-06-13 18:50 — mike kraft

Federal Government, Clinicians, Employers, and Others Should Adopt New Definition for Long COVID to Aid in Consistent Diagnosis, Documentation, and Treatment | National Academies

Country / Region Tags:

General Topic Tags:

Medical Personnel

Problem, Solution, SitRep, or ?:

Situation Report

Drug-resistant "dual mutant" flu strains, first detected in Hong Kong, now being tracked in U.S.

Thu, 2024-06-13 14:52 — mike kraft

Drug-resistant "dual mutant" flu strains now being tracked in U.S., CDC says The two genetic changes to H1N1 could cut the effectiveness of the main flu antiviral doctors turn to. CBS News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Drug-resistant "dual mutant" flu strains, first detected in Hong Kong, now being tracked in U.S.
1 comment
Log in or register to post comments

Supreme Court to hear hospital payment case; Congressional efforts against administration's nursing home staffing quotas

Tue, 2024-06-11 15:05 — mike kraft

Supreme Court will hear case claiming US underpays hospitals serving needy patients The U.S. Supreme Court has agreed to hear a lawsuit by more than 200 hospitals that serve low-income populations accusing the federal government of shortchanging them on Medicare funding by about $1.5 billion per year. Brendan Pierson Reuters

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Personnel

Problem, Solution, SitRep, or ?:

Situation Report

Paxlovid fails to improve long COVID symptoms in small study

Fri, 2024-06-07 23:13 — mike kraft

Paxlovid fails to improve long COVID symptoms in small study Using the popular COVID antiviral Paxlovid failed to significantly improve symptoms in 155 patients experiencing moderate to severe long COVID, according to a study published today in JAMA Internal Medicine. CIDRAP

...

The findings are part of the STOP-PASC trial, and the study was conducted at Stanford University from November 2022 to September 2023. All enrollees reported at least 3 months of postacute sequelae of SARS-CoV-2 infection (PASC) symptoms.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Paxlovid fails to improve long COVID symptoms in small study
Log in or register to post comments

Pages

Page loaded in 0.611 seconds.